{"entity":{"type":"insider","cik":"0001816160","url":"/insider/0001816160","json_url":"/insider/0001816160.json","name":"Kihara James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":25,"first":"2022-02-25","last":"2026-06-29","span_basis":"filed_date"},"name_variants":[{"name":"Kihara James","source":"filing","n_filings":25,"first_seen":"2022-02-25","last_seen":"2026-06-29"}],"transactions":[{"id":5759026,"accession":"0001816160-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001816160-26-000009","line_url":"/filing/0001816160-26-000009#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11421.0,"shares_display":"11,421","price_per_share":26.0846,"price_display":"26.08","price_state":"stated","total_value":297912.2166,"total_display":"297,912.22","total_whole":"297,912","shares_owned_after":13088.0,"shares_owned_after_display":"13,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-29","scope":"insider"},{"id":6180632,"accession":"0001816160-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001816160-26-000008","line_url":"/filing/0001816160-26-000008#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5401.0,"shares_display":"5,401","price_per_share":21.18,"price_display":"21.18","price_state":"stated","total_value":114393.18,"total_display":"114,393.18","total_whole":"114,393","shares_owned_after":24509.0,"shares_owned_after_display":"24,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-27","scope":"insider"},{"id":5937851,"accession":"0001816160-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001816160-26-000007","line_url":"/filing/0001816160-26-000007#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1332.0,"shares_display":"1,332","price_per_share":21.79,"price_display":"21.79","price_state":"stated","total_value":29024.28,"total_display":"29,024.28","total_whole":"29,024","shares_owned_after":29129.0,"shares_owned_after_display":"29,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-05","scope":"insider"},{"id":6047152,"accession":"0001816160-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001816160-26-000005","line_url":"/filing/0001816160-26-000005#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1030.0,"shares_display":"1,030","price_per_share":22.2,"price_display":"22.20","price_state":"stated","total_value":22866.0,"total_display":"22,866.00","total_whole":"22,866","shares_owned_after":27865.0,"shares_owned_after_display":"27,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-07","scope":"insider"},{"id":6047147,"accession":"0001816160-26-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001816160-26-000003","line_url":"/filing/0001816160-26-000003","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1109.0,"shares_display":"1,109","price_per_share":21.650814788097385,"price_display":"21.65","price_state":"stated","total_value":24010.7536,"total_display":"24,010.75","total_whole":"24,011","shares_owned_after":26897.0,"shares_owned_after_display":"26,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-26","scope":"insider","n_lines":2},{"id":6047141,"accession":"0001816160-26-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001816160-26-000003","line_url":"/filing/0001816160-26-000003#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":833.0,"shares_display":"833","price_per_share":21.47,"price_display":"21.47","price_state":"stated","total_value":17884.51,"total_display":"17,884.51","total_whole":"17,885","shares_owned_after":25852.0,"shares_owned_after_display":"25,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-26","scope":"insider"},{"id":5178641,"accession":"0001816160-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001816160-25-000004","line_url":"/filing/0001816160-25-000004#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4084.0,"shares_display":"4,084","price_per_share":23.6909,"price_display":"23.69","price_state":"stated","total_value":96753.6356,"total_display":"96,753.64","total_whole":"96,754","shares_owned_after":25058.0,"shares_owned_after_display":"25,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":4051034,"accession":"0001415889-25-013742","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-013742","line_url":"/filing/0001415889-25-013742","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":22395.0,"shares_owned_after_display":"22,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider","n_lines":2},{"id":4382490,"accession":"0001415889-25-011875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-011875","line_url":"/filing/0001415889-25-011875#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1327.0,"shares_display":"1,327","price_per_share":14.6,"price_display":"14.60","price_state":"stated","total_value":19374.2,"total_display":"19,374.20","total_whole":"19,374","shares_owned_after":23526.0,"shares_owned_after_display":"23,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-02","scope":"insider"},{"id":4707454,"accession":"0001415889-25-010423","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-010423","line_url":"/filing/0001415889-25-010423#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1028.0,"shares_display":"1,028","price_per_share":14.82,"price_display":"14.82","price_state":"stated","total_value":15234.96,"total_display":"15,234.96","total_whole":"15,235","shares_owned_after":22257.0,"shares_owned_after_display":"22,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-08","filed_date":"2025-04-08","scope":"insider"},{"id":4466904,"accession":"0001415889-25-009075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-009075","line_url":"/filing/0001415889-25-009075#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1095.0,"shares_display":"1,095","price_per_share":17.05,"price_display":"17.05","price_state":"stated","total_value":18669.75,"total_display":"18,669.75","total_whole":"18,670","shares_owned_after":21275.0,"shares_owned_after_display":"21,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-26","scope":"insider"},{"id":4919229,"accession":"0001415889-25-005575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-005575","line_url":"/filing/0001415889-25-005575#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":475.0,"shares_display":"475","price_per_share":19.96,"price_display":"19.96","price_state":"stated","total_value":9481.0,"total_display":"9,481.00","total_whole":"9,481","shares_owned_after":20228.0,"shares_owned_after_display":"20,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-25","scope":"insider"},{"id":2071015,"accession":"0001415889-24-027293","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-027293","line_url":"/filing/0001415889-24-027293#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4073.0,"shares_display":"4,073","price_per_share":16.81,"price_display":"16.81","price_state":"stated","total_value":68467.13,"total_display":"68,467.13","total_whole":"68,467","shares_owned_after":19863.0,"shares_owned_after_display":"19,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-19","scope":"insider"},{"id":2755030,"accession":"0001415889-24-012236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012236","line_url":"/filing/0001415889-24-012236#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1326.0,"shares_display":"1,326","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":22462.44,"total_display":"22,462.44","total_whole":"22,462","shares_owned_after":14370.0,"shares_owned_after_display":"14,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2222160,"accession":"0001415889-24-010602","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-010602","line_url":"/filing/0001415889-24-010602","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1790.0,"shares_display":"1,790","price_per_share":17.87,"price_display":"17.87","price_state":"stated","total_value":31987.3,"total_display":"31,987.30","total_whole":"31,987","shares_owned_after":13862.0,"shares_owned_after_display":"13,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-09","scope":"insider","n_lines":2},{"id":2484097,"accession":"0001415889-24-005574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-005574","line_url":"/filing/0001415889-24-005574#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (PRINCIPAL ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRINCIPAL ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":474.0,"shares_display":"474","price_per_share":24.67,"price_display":"24.67","price_state":"stated","total_value":11693.58,"total_display":"11,693.58","total_whole":"11,694","shares_owned_after":11391.0,"shares_owned_after_display":"11,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":8471516,"accession":"0001209191-23-058891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058891","line_url":"/filing/0001209191-23-058891#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":28.3,"price_display":"28.30","price_state":"stated","total_value":56600.0,"total_display":"56,600.00","total_whole":"56,600","shares_owned_after":11025.0,"shares_owned_after_display":"11,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-15","scope":"insider"},{"id":7817001,"accession":"0001209191-23-056354","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-056354","line_url":"/filing/0001209191-23-056354#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1985.0,"shares_display":"1,985","price_per_share":22.64,"price_display":"22.64","price_state":"stated","total_value":44940.4,"total_display":"44,940.40","total_whole":"44,940","shares_owned_after":13025.0,"shares_owned_after_display":"13,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":7899515,"accession":"0001209191-23-050072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050072","line_url":"/filing/0001209191-23-050072#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.88,"price_display":"25.88","price_state":"stated","total_value":51760.0,"total_display":"51,760.00","total_whole":"51,760","shares_owned_after":10778.0,"shares_owned_after_display":"10,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-19","scope":"insider"},{"id":8188661,"accession":"0001209191-23-037932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037932","line_url":"/filing/0001209191-23-037932#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":24.15,"price_display":"24.15","price_state":"stated","total_value":48300.0,"total_display":"48,300.00","total_whole":"48,300","shares_owned_after":9144.0,"shares_owned_after_display":"9,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-16","scope":"insider"},{"id":8294395,"accession":"0001209191-23-031245","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-031245","line_url":"/filing/0001209191-23-031245#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5947.0,"shares_display":"5,947","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":133807.5,"total_display":"133,807.50","total_whole":"133,808","shares_owned_after":11144.0,"shares_owned_after_display":"11,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-19","scope":"insider"},{"id":8365641,"accession":"0001209191-23-024061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024061","line_url":"/filing/0001209191-23-024061#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":523.0,"shares_display":"523","price_per_share":18.14,"price_display":"18.14","price_state":"stated","total_value":9487.22,"total_display":"9,487.22","total_whole":"9,487","shares_owned_after":5197.0,"shares_owned_after_display":"5,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-11","scope":"insider"},{"id":8628551,"accession":"0001209191-23-023864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023864","line_url":"/filing/0001209191-23-023864#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":18.16,"price_display":"18.16","price_state":"stated","total_value":12730.16,"total_display":"12,730.16","total_whole":"12,730","shares_owned_after":4231.0,"shares_owned_after_display":"4,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-07","scope":"insider"},{"id":8019088,"accession":"0001209191-23-013471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013471","line_url":"/filing/0001209191-23-013471#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":18.78,"price_display":"18.78","price_state":"stated","total_value":6573.0,"total_display":"6,573.00","total_whole":"6,573","shares_owned_after":2923.0,"shares_owned_after_display":"2,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":6351533,"accession":"0001209191-22-024064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-024064","line_url":"/filing/0001209191-22-024064#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1025.0,"shares_display":"1,025","price_per_share":27.05,"price_display":"27.05","price_state":"stated","total_value":27726.25,"total_display":"27,726.25","total_whole":"27,726","shares_owned_after":2433.0,"shares_owned_after_display":"2,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-11","scope":"insider"},{"id":6542311,"accession":"0001209191-22-013286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013286","line_url":"/filing/0001209191-22-013286#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001816160","owner_name":"Kihara James","owner_display_name":"Kihara James","owner_url":"/insider/0001816160","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":359.0,"shares_display":"359","price_per_share":23.8,"price_display":"23.80","price_state":"stated","total_value":8544.2,"total_display":"8,544.20","total_whole":"8,544","shares_owned_after":481.0,"shares_owned_after_display":"481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (PRINCIPAL ACCOUNTING OFFICER)","n_filings":25,"first_seen":"2022-02-25","last_seen":"2026-06-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001816160","retrieved_at":"2026-08-25T19:18:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}